Abstract:Vascular endothelial cells (ECs), locating at the inner side of vascular lumen, play critical roles in maintaining vascular function and participate in tissue repair and neovascularization. Although increasing studies have shown positive effects of transplantation of vascular ECs or their precursor cells on neovascularization and functional recovery of ischemic tissues, the quantity of in vivo ECs is limited and their quality is affected by age, gender, disease, and others, which hinder their clinical application and further study. Chemical transdifferentiation is a promising approach to generate patient-specific cells. In this process, somatic cells are directly converted into desired cell types without the risk of tumorigenicity by pluripotent cell transplantation and exogenous gene introduction by transgene technology. In the present study, we derived ECs from human cardiac fibroblasts (CFs) through an optimized chemical induction method. The derived ECs expressed endothelial specific markers, took up low-density lipoprotein, secreted angiogenic cytokines under hypoxic condition, and formed microvessels in vitro and in vivo. This CF-EC transition bypassed pluripotency and germ layer differentiation, but underwent a stage of endothelialization. Although p53 maintained the same level during the period of CF-EC transdifferentiation, we could modulate p53 transcriptional activity to further improve cell transition efficiency, which mainly functioned at the later stage of endothelialization. Optimization and exploring the regulatory mechanism of CF-EC transition complement each other, which not only broadens the sources of patient-specific ECs but also provides valuable references for the in vivo direct transdifferentiation study and the elucidation of endothelial development and dysfunction. Impact statement This study provides an optimized chemical induction method to derive endothelial cells (ECs) from human cardiac fibroblasts (CFs), which not only broadens the sources of patient-specific ECs but also provides a good research model of mesenchymal-endothelial transition. Studying the molecular process and regulatory mechanism of CF-EC transdifferentiation will provide valuable references for the in vivo direct transdifferentiation for clinical therapy and deepen the understanding of endothelial development and dysfunction.

Advancement of Endothelial-to-mesenchymal Transition in Cardiovascular system

Research progress of endothelial-to-mesenchymal transition

The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease

Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering

In Brief: Endothelial-To-Mesenchymal Transition

Advances in regulating endothelial-mesenchymal transformation through exosomes

Endothelial to mesenchymal transition in cardiovascular diseases: Developmental signalling pathways gone awry.

EndMT: A promising and controversial field

Epithelial-mesenchymal Transition (EMT): A Biological Process in the Development, Stem Cell Differentiation, and Tumorigenesis

Pathophysiology of transdifferentiation

Endothelial-to-mesenchymal transition: New insights into vascular calcification

The Therapeutic Potential of Targeting the Endothelial-to-mesenchymal Transition

P53 Activation Facilitates Transdifferentiation of Human Cardiac Fibroblasts into Endothelial Cells.

Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases

An updated view on the differentiation of stem cells into endothelial cells

Histone modification of endothelial-mesenchymal transition in cardiovascular diseases

Endothelial and smooth muscle cell transformation in atherosclerosis.

The Key Role of Mesenchymal to Epithelial Transition in Tumor Pathogenesis and Progression

TGF--mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases